Literature DB >> 25385688

BRAF, NRAS and MC1R status in a prospective series of primary cutaneous melanoma.

Z García-Casado1, V Traves, J Bañuls, M Niveiro, E Gimeno-Carpio, A I Jimenez-Sanchez, M Moragón, J A Onrubia, V Oliver, R Kumar, E Nagore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25385688     DOI： 10.1111/bjd.13521

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  8 in total

1.  Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in Melanoma.

Authors:  Nancy E Thomas; Sharon N Edmiston; Peter A Kanetsky; Klaus J Busam; Anne Kricker; Bruce K Armstrong; Anne E Cust; Hoda Anton-Culver; Stephen B Gruber; Li Luo; Irene Orlow; Anne S Reiner; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Lidia Sacchetto; Terence Dwyer; Eloise A Parrish; Honglin Hao; David C Gibbs; Jill S Frank; David W Ollila; Colin B Begg; Marianne Berwick; Kathleen Conway
Journal:  J Invest Dermatol       Date:  2017-08-24       Impact factor: 8.551

Review 2.  Dermoscopic Features as Predictors of BRAF Mutational Status and Sentinel Lymph Node Positivity in Primary Cutaneous Melanoma.

Authors:  Nika Filipović; Mirna Šitum; Marija Buljan
Journal:  Dermatol Pract Concept       Date:  2021-04-12

3.  Risk factors for keratinocyte skin cancer in patients diagnosed with melanoma, a large retrospective study.

Authors:  Pablo Espinosa; Ruth M Pfeiffer; Zaida García-Casado; Celia Requena; Maria Teresa Landi; Rajiv Kumar; Eduardo Nagore
Journal:  Eur J Cancer       Date:  2015-12-17       Impact factor: 9.162

4.  BRAF-V600E expression in primary nodular melanoma is associated with aggressive tumour features and reduced survival.

Authors:  Emilia Hugdahl; May Britt Kalvenes; Hanne E Puntervoll; Rita G Ladstein; Lars A Akslen
Journal:  Br J Cancer       Date:  2016-02-25       Impact factor: 7.640

5.  Cutaneous melanoma primary site is linked to nevus density.

Authors:  Alejandro Martin-Gorgojo; Marta Llinares; Amaya Virós; Celia Requena; Zaida Garcia-Casado; Víctor Traves; Rajiv Kumar; Eduardo Nagore
Journal:  Oncotarget       Date:  2017-10-24

6.  Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations.

Authors:  William Bruno; Claudia Martinuzzi; Bruna Dalmasso; Virginia Andreotti; Lorenza Pastorino; Francesco Cabiddu; Marina Gualco; Francesco Spagnolo; Alberto Ballestrero; Paola Queirolo; Federica Grillo; Luca Mastracci; Paola Ghiorzo
Journal:  Oncotarget       Date:  2017-12-14

Review 7.  Defining the Criteria for Reflex Testing for BRAF Mutations in Cutaneous Melanoma Patients.

Authors:  Sarah Zhou; Daniel Sikorski; Honghao Xu; Andrei Zubarev; May Chergui; François Lagacé; Wilson H Miller; Margaret Redpath; Stephanie Ghazal; Marcus O Butler; Teresa M Petrella; Joël Claveau; Carolyn Nessim; Thomas G Salopek; Robert Gniadecki; Ivan V Litvinov
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

Review 8.  Behind the Scene: Exploiting MC1R in Skin Cancer Risk and Prevention.

Authors:  Michele Manganelli; Stefania Guida; Anna Ferretta; Giovanni Pellacani; Letizia Porcelli; Amalia Azzariti; Gabriella Guida
Journal:  Genes (Basel)       Date:  2021-07-19       Impact factor: 4.096
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.